Having medication available prevents panic when symptoms randomly return
Patients with a history of medullary thyroid carcinoma, pancreatitis, or severe gastrointestinal disease are typically excluded
In the original 2015 Cell Metabolism paper, MOTS-c activated AMPK, improved insulin sensitivity in diet-induced obese mice, and reduced age-related insulin resistance in older animals [2]
Absence of many reports is not proof of low risk BPC-157 use is difficult to measure, products may be sold outside conventional medical channels, and adverse events may never be recognized or reported
Elevated zonulin levels are associated with Leaky Gut SYndrome, and have been linked to a number of conditions such as celiac disease, type 1 diabetes, and inflammatory bowel disease
Long-term use safety Traditional pain meds: Not safe for years of continuous use Require breaks or rotation Accumulating damage to organs Peptides: Can use for months to years safely BPC-157 and TB-500 have decades of use data No cumulative toxicity Actually heal tissue rather than damage it Combining peptides with pain medications Can use together: Peptides for healing NSAIDs for acute breakthrough pain Reduce medication dose as peptides work Transition plan: Start peptides while on pain meds As pain improves, reduce medication slowly Goal: Minimal or no pain meds long-term See our peptide safety and risks guide
